Disruption of RBMS3 suppresses PD-L1 and enhances antitumor immune activities and therapeutic effects of auranofin against triple-negative breast cancer.
Zhou Y, Liang Z, Xia Y, Li S, Liang J, Hu Z, Tang C, Zhao Q, Gong Q, Ouyang Y. Chem Biol Interact. 2023 Jan 5; 369:110260. Epub 2022 Nov 19.